ranolazine

It is used for the treatment of stable angina, specifically as a monotherapy or as an add-on to other therapies if they do not provide sufficient results.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Menarini-von Heyden GmbH (manufacturing "in bulk", packaging, control and batch release)

It is used for the treatment of stable angina.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Menarini-von Heyden GmbH (manufacturing "in bulk", packaging, control and batch release)

The drug is prescribed for the treatment of stable angina.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Adamed Pharma S.A. (manufacturing of unpackaged product, primary and secondary packaging, batch control, batch release)

The drug is indicated for the treatment of stable angina pectoris.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Adamed Pharma S.A. (manufacturing of unpackaged product, primary and secondary packaging, batch control, batch release)

The drug is used for the symptomatic treatment of stable angina pectoris. It may be prescribed either as monotherapy or in combination with other medications if previous therapy methods have not provided sufficient effect or have caused intolerance.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Farmak JSC

The drug is used for the symptomatic treatment of stable angina pectoris. It may be prescribed either as monotherapy or in combination with other medications if previous therapy methods have not provided sufficient effect or have caused intolerance.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Farmak JSC

The drug is used for the symptomatic treatment of stable angina. It may be prescribed either as monotherapy or in combination with other medicines if previous therapy methods have not provided sufficient effect or have caused intolerance.

Form: tablets, extended-release

ATC: C01EB18

Manufacturer: Farmak JSC